Drug Commercialization Before the Pricing and Reimbursement in Italy: The Non Negotiated C Class (C-Nn)

Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.1673
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Php210 - Development of Drug Innovativness Assessment Tool for Decision-Making in Reimbursement and Pricing

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcp37 - The Confidentiality Regarding Drugs Pricing and Reimbursement in Romania

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Phylogeny and Phylodinamic of Hepatitis C in Italy

BMC Infectious Diseases
Infectious Diseases
2012English

Prm7 Drug Development and Pharmaceutical Pricing in the United States: The Influence of Drug Intended Outcomes of Drug Pricing

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Pricing and Reimbursement of Orphan Drugs: The Need for More Transparency

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2011English

Non-Injection Drug Use and Hepatitis C Virus: A Systematic Review

Drug and Alcohol Dependence
PsychiatryToxicologyMental HealthPharmacology
2007English

Php78 - Pricing and Reimbursement Reforms in Spain – A Systematic Analysis of National Pricing Decisions by the Cipm

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Some Fixed Point Theorems in an Intuitionistic Menger Space via C -Class and Inverse C -Class Functions

Computational and Mathematical Methods
2020English

Universal Chronicles in Arabic Before C. 900

Medieval Worlds
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy